Both models highlight that the massive $20B upsized offering creates a significant dilution overhang (210M+ shares) that will pressure the stock toward the $90-$91 range if the $95.00 floor fails. They point to deteriorating technicals, including a breakdown of the 4h SMA50 ($97.81) and negative margins (-19.8%), as evidence that the fundamental floor is weak. One model warns that the 30-day greenshoe option will keep additional supply overhanging the market, while another notes the absurd 809x trailing P/E and sector-wide weakness in the XLK as reasons for further downside.
Both models agree that the $20B equity offering priced at $95.00 creates a natural technical floor, with the stock currently testing stacked support near $95.35-$95.47 while deeply oversold (30-min RSI at 23.66). They anticipate a mean-reversion bounce toward the $101-$107 value area over 1-3 weeks as the dilution overhang dissipates and the market refocuses on the Q2 earnings beat and strong Q3 revenue guidance ($15.8-16.8B). One model specifically notes that the $19.7B in proceeds will fund critical foundry capex, turning a known dilution event into a fundamental catalyst.
Intel just priced a hugely dilutive $20B primary equity offering at $95.00 while running negative margins (-19.8%), a Q2 EPS of $(2.16), and an absurd 809x trailing P/E, so the fundamental floor is weak and every rally is met with fresh supply. The stock is already -6% today and confirming XLK sector weakness; a clean breakdown below the $95.35/$95.47 support shelf and the $95.00 offering price would open a path toward the lower value area near $90-$91. I want confirmation of that support break before pressing, because shorting directly on support after an extended down move has poor entry location.
INTC has capitulated ~6% on completion/pricing of its $20B equity offering at $95.00, but that offering price now anchors a technical floor with price holding just above $95.35/ $95.47 support and 30-minute RSI at a deeply oversold 23.66 below the lower Bollinger band. With dilution now a known/priced event rather than a forward overhang, an oversold bounce back toward the $98.33- $98.58 resistance and the $101.90 POC is the higher-probability near-term path. A supportive long cohort prior (62% shrunk win, +0.75R) and a calm stock-picker regime favor mean-reversion from this washed-out level over 1-3 weeks.
Intel's $20B upsized stock offering priced at $95.00 creates massive dilution overhang (210M+ shares) that will pressure the stock toward and below the offering price as the market absorbs supply. The stock is already breaking down through the 4h SMA50 ( $97.81) with falling RSI on both daily and 4h timeframes, confirming the bearish momentum. With the offering proceeds likely used for capex-intensive foundry buildout amid negative margins (-19.8%) , the dilution story has room to play out over the next 1-3 weeks as the 30-day greenshoe option keeps additional supply overhanging the market.
Intel's $20B stock offering priced at $95.00 creates a natural floor, and the stock is now trading just 2.2% above that level with 30-min RSI at 23.66 (deeply oversold) while testing stacked 4h/1d support near $95.35-95.47. The massive Q2 earnings beat (EPS $0.42 vs $0.22 est) and strong forward guidance ($15.8-16.8B Q3 revenue) show the fundamental turnaround is intact, and the offering overhang should dissipate as the $19.7B in proceeds fund capex for Intel's foundry buildout. We expect mean reversion toward the $101-107 value area over 1-3 weeks as selling exhaustion sets in and the offering floor holds.
The runs did not produce a directional majority. 2 of 3 matching votes were required.
No-vote detail: 2 abstentions